Kylin Liao (Tag Archives)
Subscribe to PricePlow's Newsletter and Kylin Liao Alerts
Rob Rogers: goBHB is Back! Business, Baseball, and BHB | Episode #131
For Episode #131 of the PricePlow Podcast, we sat down with Rob Rogers from Axcess Global, the parent company of Ketone Labs, Real Ketones, Vault, and many others. Ketone Labs is best known for selling goBHB, the patented exogenous BHB dietary supplement ingredient — which is the main topic […]
Continue Reading →
2022 Supplement Industry Awards | Episode #079
It’s that time of year again — time for PricePlow’s 2022 Supplement Industry Awards. Mike and Ben sat down to review 2022, and then got into a batch of awards similar to what we did in the 2021 Supplement Industry Awards.
2022 brought some great new ingredient innovations, but also came with some heartbreaking […]
Continue Reading →
Raza Bashir & Shawn Wells: MuscleTech enfinity Paraxanthine Launch | Episode #072
https://blog.priceplow.com/podcast/raza-bashir-shawn-wells-muscletech-enfinity-paraxanthine-072
In late August of 2022, PricePlow revealed the next-generation stimulatory ingredient enfinity (Paraxanthine), set to launch shortly afterward through MuscleTech. We wrote about the new product line and briefly introduced paraxanthine to readers in our article titled MuscleTech Reveals New Workout Stimulant: enfinity brand Paraxanthine.
To follow-up with more scientific […]
Continue Reading →
The Power of “Mito”: Optimizing the Mitochondria to Unlock Clean Energy!
When looking for an additional boost in energy, we often turn to stimulants and other supplements to provide a jolt. While this usually does the trick temporarily, how often do we take a step back and ask why we needed the kickstart to begin with? Maybe the previous night’s sleep wasn’t great, or a tough […]
Continue Reading →
The NNB Nutrition Story: Supplement Ingredient Solutions for the New Decade
For the latter part of the 2010s, the supplement industry suffered from a serious case of technological stagnation, especially in the “sports nutrition” segment. Very few new ingredients entered the market, and of those, many were simply minor tweaks of old compounds or questionably compliant stimulants.
All the while, the obesity epidemic and all […]
Continue Reading →
